Clinical Trial Update: Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating 18F-DOPA-PET imaging in metastatic melanoma patients treated with B-RAF inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• B-RAF inhibitors

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED